.
RO financial statements
* Numbers in millions
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Capitalization * |
138 727 | 171 890 | 211 237 | 214 585 | 223 175 | 203 458 | 200 114 | 218 624 | 275 118 | 268 470 | 327 294 |
EV * |
161 726 | 191 950 | 225 880 | 236 557 | 242 695 | 221 650 | 214 355 | 230 713 | 284 625 | 278 154 | 278 154 |
Stock price ¤ |
163.4 | 202.7 | 249.1 | 252.75 | 262.25 | 238.8 | 234.6 | 256 | 321.4 | 314 | 382.8 |
Number of shares * |
849 | 848 | 848 | 849 | 851 | 852 | 853 | 854 | 856 | 855 | 855 |
EPS |
11,00 | 11,25 | 13,17 | 10,99 | 10,41 | 11,24 | 10,12 | 12,30 | 15,77 | 16,72 | 16,72 |
Revenue * |
42 531 | 45 499 | 46 780 | 47 462 | 48 145 | 50 576 | 53 299 | 56 846 | 61 466 | 58 323 | 58 323 |
Net income * |
9 343 | 9 539 | 11 164 | 9 332 | 8 863 | 9 576 | 8 633 | 10 500 | 13 497 | 14 295 | 14 295 |
Operating profit * |
13 439 | 14 113 | 16 376 | 14 090 | 13 821 | 14 069 | 13 003 | 14 743 | 17 548 | 18 543 | 18 543 |
Total liabilities * |
47 094 | 48 077 | 40 926 | 54 083 | 52 463 | 50 417 | 47 669 | 48 151 | 47 224 | 46 365 | 46 365 |
Net debt * |
22 999 | 20 060 | 14 643 | 21 972 | 19 520 | 18 192 | 14 241 | 12 089 | 9 507 | 9 684 | 9 684 |
Total assets * |
61 576 | 64 805 | 62 167 | 75 641 | 75 763 | 76 819 | 76 676 | 78 517 | 83 091 | 86 138 | 86 138 |
Equity * |
12 095 | 14 494 | 19 294 | 19 586 | 20 979 | 23 911 | 26 441 | 27 622 | 32 747 | 36 341 | 36 341 |
Cash and investments * |
11 287 | 13 991 | 11 935 | 11 703 | 9 171 | 9 107 | 11 997 | 13 118 | 11 858 | 12 334 | 12 334 |
Over the past 10 years, the maximum capitalization of Roche Holding AG is 275 118, the minimum is 138 727. Maximum net income 14 295, Minimum net income 8 633. The maximum price of RO shares is 321.4, the minimum price is 163.4.
.
RO valuation
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
14,85 | 18,02 | 18,92 | 22,99 | 25,18 | 21,25 | 23,18 | 20,82 | 20,38 | 18,78 | 22,90 |
P/B |
11,47 | 11,86 | 10,95 | 10,96 | 10,64 | 8,51 | 7,57 | 7,91 | 8,40 | 7,39 | 9,01 |
P/S |
3,26 | 3,78 | 4,52 | 4,52 | 4,64 | 4,02 | 3,75 | 3,85 | 4,48 | 4,60 | 5,61 |
E/P |
7% | 6% | 5% | 4% | 4% | 5% | 4% | 5% | 5% | 5% | 4% |
P/FCF |
12,91 | 13,64 | 16,35 | 17,04 | 20,03 | 20,64 | 14,49 | 14,52 | 15,73 | 22,61 | 27,56 |
.
RO profitability
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
ROE |
77% | 66% | 58% | 48% | 42% | 40% | 33% | 38% | 41% | 39% | |
ROA |
19% | 18% | 22% | 18% | 17% | 18% | 15% | 17% | 22% | 22% | |
ROIC |
30% | 32% | 35% | 27% | 27% | 26% | 24% | 27% | 30% | 31% |